Design, synthesis and evaluation of novel thienopyrimidine-based agents bearing diaryl urea functionality as potential inhibitors of angiogenesis

Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods

Jacques Ferlay, Murielle Colombet, Isabelle Soerjomataram et al. · International Journal of Cancer · 2018 · 7.8K citations · Full text

Medicine, Oncology, Cancer Epidemiology +16

Distinct Binding Mode of Multikinase Inhibitor Lenvatinib Revealed by Biochemical Characterization

Kiyoshi Okamoto, Megumi Ikemori‐Kawada, A. Jestel et al. · ACS Medicinal Chemistry Letters · 2014 · 278 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Vascular Endothelial Growth Factor (VEGF) Receptors: Drugs and New Inhibitors

Francesca Musumeci, Marco Radi, Chiara Brullo et al. · Journal of Medicinal Chemistry · 2012 · 188 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Discovery of Potent VEGFR-2 Inhibitors based on Furopyrimidine and Thienopyrimidne Scaffolds as Cancer Targeting Agents

M. Abdel Aziz, Rabah A.T. Serya, Deena S. Lasheen et al. · Scientific Reports · 2016 · 174 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

SKLB1002, a Novel Potent Inhibitor of VEGF Receptor 2 Signaling, Inhibits Angiogenesis and Tumor Growth <i>In Vivo</i>

Shuang Zhang, Zhixing Cao, Hongwei Tian et al. · Clinical Cancer Research · 2011 · 101 citations

Medicine, Oncology, Pharmacology +15